TAG:
laboratories
LabCorp Talks to Its Clients About Service Enhancements
By Robert Michel | From the Volume XV No. 16 – December 01, 2008 Issue
BOTH NATIONAL LABORATORIES now face a future where growth is not likely to come from a steady stream of sizeable laboratory acquisitions. That makes service enhancements a more important way to protect market share and build client loyalty. At Laboratory Corporation of America, this…
Multi-Modality Diagnosis Heading for Lab Medicine
By Robert Michel | From the Volume XV No. 16 – December 01, 2008 Issue
CEO Summary: At the upcoming Molecular Summit in Philadelphia on February 10-11, 2009, pathologists, molecular imaging experts, and informaticians will share the latest developments on the integration of in vivo (imaging) and in vitro (pathology) diagnost…
2008’s Top Ten Lab Stories Lacked Disruptive Impact
By Robert Michel | From the Volume XV No. 16 – December 01, 2008 Issue
CEO SUMMARY: For the first time in recent memory, a year has passed without major tumult or disruptive change in the laboratory industry. Our list of the Top Ten Most Important Stories of 2008 reflects a rather quiet year when compared to most years of this decade. Howeve…
Massachusetts CPOE, MountainStar, PAML, HCA, Ogden Regional Medical Center, HIPAA 5010, LabCorp, Mubadala Health, KLAS
By Robert Michel | From the Volume XV No. 15 – November 10, 2008 Issue
MASSACHUSETTS LAW MANDATES CPOE USE BY HOSPITALS IN 2012 EARLIER THIS YEAR, Massachusetts passed a law that requires all hospitals in the state to implement CPOE (computerized physician order entry) by 2012. The same law requires all hospitals in the state t…
Growth Conundrum Confronts Quest and LabCorp
By R. Lewis Dark | From the Volume XV No. 15 – November 10, 2008 Issue
AFTER MORE THAN TWO DECADES of buying up almost every attractive laboratory asset that came up for sale—and with few lab acquisition candidates left to buy—Laboratory Corporation of America and Quest Diagnostics Incorporated find themselves in an interesting conu…
LabCorp And Quest Report 3rd Quarter Financial Performance
By Robert Michel | From the Volume XV No. 15 – November 10, 2008 Issue
CEO Summary: In third quarter earnings reports, both national lab companies posted modest gains in specimen volume, revenue, and net profit. More telling is the relative quiet in the current market for lab testing services. With no obvious opportunities to fuel double-digit rates of growt…
Medi-Cal Hits Pathologist For $6.4 Million Payment
By Robert Michel | From the Volume XV No. 15 – November 10, 2008 Issue
CEO SUMMARY: Once again, government health bureaucrats are overreaching in their efforts to reduce spending and collect money from any source. A California pathologist has been hit with a Medi-Cal demand for $6.4 million in repayments, simply because he served as laboratory director for t…
Rapid Genome Sequencing Predicted by Mid-2009
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
CEO SUMMARY: In the same way that the Human Genome Project was disrupted by the entry of C. Craig Venter and Perkin-Elmer in what was then a 15-year, $3 billion project, now Complete Genetics of Mountain View, California, is disrupting the race to the $1,000 human genome sequence. Develop…
Genome Sequencing Promises to be Disruptive
By R. Lewis Dark | From the Volume XV No. 14 – October 20, 2008 Issue
EVERYONE SHOULD CAREFULLY READ OUR LEAD STORY ON THE FACING PAGE. Titled “Rapid Gene Sequencing Predicted by Mid-2009,” it is a revealing look at the declaration of California-based Complete Genetics that, in less than eight months, it will begin delivering full human genome sequ…
Hospital Labs Have New Options for Molecular Dx
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
CEO SUMMARY: Laboratories that offer molecular assays continue to see strong growth in four areas: oncology, hematopathology, infectious diseases, and personalized medicine. Further, a new generation of molecular testing systems and analyzers is coming to market which will make it easier …
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized